Future of Cardiovascular Drug Development An uncertain future? It may be a difficult time for cardiovascular drug development, but there are still reasons to be positive, say Koos Burggraaf and Matthijs Moerland at the Centre for Human Drug Research.
View white paper
Proof of Pharmacological Principle Hit the mark. Joop van Gerven and Justin Hay of CHDR discuss how carefully chosen biomarkers can easily be incorporated into early phase drug studies, providing guidance for important decisions concerning a drug's future.
View white paper